QS Investors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $427K | Sell |
3,233
-1,010
| -24% | -$132K | 0.01% | 802 |
|
|
2021
Q1 | $545K | Sell |
4,243
-700
| -14% | -$86.3K | 0.01% | 760 |
|
|
2020
Q4 | $589K | Buy |
4,943
+4
| +0.1% | +$488 | 0.01% | 705 |
|
|
2020
Q3 | $566K | Sell |
4,939
-35
| -0.7% | -$4.13K | 0.01% | 634 |
|
|
2020
Q2 | $567K | Sell |
4,974
-504
| -9% | -$53.5K | 0.01% | 875 |
|
|
2020
Q1 | $440K | Sell |
5,478
-6,166
| -53% | -$638K | 0.01% | 874 |
|
|
2019
Q4 | $1.23M | Buy |
11,644
+236
| +2% | +$24.6K | 0.01% | 727 |
|
|
2019
Q3 | $1.22M | Hold |
11,408
| – | – | 0.01% | 719 |
|
|
2019
Q2 | $1.16M | Hold |
11,408
| – | – | 0.01% | 755 |
|
|
2019
Q1 | $1.03M | Sell |
11,408
-1,055
| -8% | -$91.4K | 0.01% | 802 |
|
|
2018
Q4 | $1.04M | Sell |
12,463
-962
| -7% | -$90.2K | 0.01% | 750 |
|
|
2018
Q3 | $1.45M | Hold |
13,425
| – | – | 0.01% | 713 |
|
|
2018
Q2 | $1.48M | Buy |
13,425
+115
| +0.9% | +$12K | 0.01% | 687 |
|
|
2018
Q1 | $1.33M | Sell |
13,310
-572
| -4% | -$58.6K | 0.01% | 702 |
|
|
2017
Q4 | $1.37M | Buy |
13,882
+3,331
| +32% | +$316K | 0.01% | 722 |
|
|
2017
Q3 | $988K | Hold |
10,551
| – | – | 0.01% | 814 |
|
|
2017
Q2 | $1.17M | Buy |
10,551
+568
| +6% | +$60.1K | 0.01% | 738 |
|
|
2017
Q1 | $980K | Buy |
9,983
+4,700
| +89% | +$448K | 0.01% | 803 |
|
|
2016
Q4 | $486K | Buy |
5,283
+116
| +2% | +$10K | ﹤0.01% | 889 |
|
|
2016
Q3 | $437K | Sell |
5,167
-48
| -0.9% | -$4.03K | ﹤0.01% | 914 |
|
|
2016
Q2 | $425K | Buy |
5,215
+343
| +7% | +$26.1K | ﹤0.01% | 935 |
|
|
2016
Q1 | $348K | Buy |
4,872
+240
| +5% | +$16.1K | ﹤0.01% | 973 |
|
|
2015
Q4 | $330K | Buy |
4,632
+622
| +16% | +$41.8K | ﹤0.01% | 983 |
|
|
2015
Q3 | $246K | Buy |
4,010
+345
| +9% | +$24.1K | ﹤0.01% | 1032 |
|
|
2015
Q2 | $266K | Buy |
3,665
+734
| +25% | +$54.2K | ﹤0.01% | 1008 |
|
|
2015
Q1 | $225K | Buy |
2,931
+635
| +28% | +$45.5K | ﹤0.01% | 1026 |
|
|
2014
Q4 | $154K | Sell |
2,296
-3,140
| -58% | -$198K | ﹤0.01% | 1073 |
|
|
2014
Q3 | $330K | Sell |
5,436
-400
| -7% | -$24.6K | 0.01% | 495 |
|
|
2014
Q2 | $343K | Buy |
5,836
+1,936
| +50% | +$113K | 0.01% | 508 |
|
|
2014
Q1 | $226K | Sell |
3,900
-500
| -11% | -$26.8K | 0.01% | 569 |
|
|
2013
Q4 | $235K | Sell |
4,400
-400
| -8% | -$23.7K | 0.01% | 542 |
|
|
2013
Q3 | $297K | Sell |
4,800
-1,000
| -17% | -$59.9K | 0.01% | 513 |
|
|
2013
Q2 | $351K | Buy |
+5,800
| New | +$346K | 0.01% | 568 |
|
Other funds holding DGX
FMI
DSA
QS Investors's DGX Position: Q2 2021 in Review
QS Investors reduced its Quest Diagnostics (DGX) stake by 24% in Q2 2021, selling an estimated $132K and leaving 3,233 shares worth $427K. The position accounts for 0.01% of the portfolio, ranked #802.
QS Investors first reported a position in DGX in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.48M in Q2 2018. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.
- QS Investors held 3,233 shares of Quest Diagnostics worth $427K as of Q2 2021.
- QS Investors sold 1,010 Quest Diagnostics shares in Q2 2021, an estimated $132K.
- Quest Diagnostics made up 0.01% of QS Investors's portfolio in Q2 2021, its #802 holding.
- QS Investors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Quest Diagnostics position peaked at $1.48M in Q2 2018.
- 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.